Pfizer CDR (CAD Hedged) (PFE:TSX) closed at $13.23 on October 26, 2026, down 0.68% on the day. The stock trades 2.1% below its 52-week high of $13.52 and 25.2% above its 52-week low of $10.57. Over the past year, it gained 15.8%. Pfizer CDR (CAD Hedged) is part of the Health Care sector.
In 210 trading sessions since December 23, 2025, PFE closed higher on 103 days (49%). Its best day was February 4, 2026 (+3.87%) and its worst was February 3, 2026 (-3.32%). It never moved 10% or more in a single session.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For over 175 years, we have worked to make a difference for all who rely on us.
Find more stocks like PFE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.